Cargando…

Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?

OBJECTIVE: During the COVID-19 pandemic, it is essential to understand if and how to screen SARS-CoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Gervasi, Salvatore Francesco, Pengue, Luca, Damato, Luca, Monti, Riccardo, Pradella, Silvia, Pirronti, Tommaso, Bartoloni, Alessandro, Epifani, Francesco, Saggese, Alessio, Cuccaro, Francesco, Bianco, Massimiliano, Zeppilli, Paolo, Palmieri, Vincenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536638/
https://www.ncbi.nlm.nih.gov/pubmed/33020140
http://dx.doi.org/10.1136/bjsports-2020-102789
_version_ 1783590607428517888
author Gervasi, Salvatore Francesco
Pengue, Luca
Damato, Luca
Monti, Riccardo
Pradella, Silvia
Pirronti, Tommaso
Bartoloni, Alessandro
Epifani, Francesco
Saggese, Alessio
Cuccaro, Francesco
Bianco, Massimiliano
Zeppilli, Paolo
Palmieri, Vincenzo
author_facet Gervasi, Salvatore Francesco
Pengue, Luca
Damato, Luca
Monti, Riccardo
Pradella, Silvia
Pirronti, Tommaso
Bartoloni, Alessandro
Epifani, Francesco
Saggese, Alessio
Cuccaro, Francesco
Bianco, Massimiliano
Zeppilli, Paolo
Palmieri, Vincenzo
author_sort Gervasi, Salvatore Francesco
collection PubMed
description OBJECTIVE: During the COVID-19 pandemic, it is essential to understand if and how to screen SARS-CoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoiding inappropriate examinations. METHODS: We conducted a cohort study of a professional soccer team that is based on an extensive screening protocol for resuming training during the COVID-19 pandemic. It included personal history, antigen swabs, blood tests, spirometry, resting/stress-test ECG with oxygen saturation monitoring, echocardiogram, Holter and chest CT. We also compared the findings with prior data from the same subjects before infection and with data from SARS-CoV-2-negative players. RESULTS: None of the players had positive swab and/or anti-SARS-CoV-2 IgM class antibodies. Out of 30 players, 18 (60%) had IgG class antibodies. None had suffered severe SARS-CoV-2-related disease, 12 (66.7%) had complained of mild COVID-19-related symptoms and 6 (33.3%) were asymptomatic. None of the players we examined revealed significant cardiovascular abnormalities after clinical recovery. A mild reduction in spirometry parameters versus pre-COVID-19 values was observed in all athletes, but it was statistically significant (p<0.05) only in SARS-CoV-2-positive athletes. One SARS-CoV-2-positive player showed increased troponin I level, but extensive investigation did not show signs of myocardial damage. CONCLUSION: In this small cohort of athletes with previous asymptomatic/mild SARS-CoV-2 infection, a comprehensive screening protocol including blood tests, spirometry, resting ECG, stress-test ECG with oxygen saturation monitoring and echocardiogram did not identify relevant anomalies. While larger studies are needed, extensive cardiorespiratory and haematological screening in athletes with asymptomatic/mild SARS-CoV-2 infection appears unnecessary.
format Online
Article
Text
id pubmed-7536638
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-75366382020-10-06 Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection? Gervasi, Salvatore Francesco Pengue, Luca Damato, Luca Monti, Riccardo Pradella, Silvia Pirronti, Tommaso Bartoloni, Alessandro Epifani, Francesco Saggese, Alessio Cuccaro, Francesco Bianco, Massimiliano Zeppilli, Paolo Palmieri, Vincenzo Br J Sports Med Original Research OBJECTIVE: During the COVID-19 pandemic, it is essential to understand if and how to screen SARS-CoV-2-positive athletes to safely resume training and competitions. The aim of this study is to understand which investigations are useful in a screening protocol aimed at protecting health but also avoiding inappropriate examinations. METHODS: We conducted a cohort study of a professional soccer team that is based on an extensive screening protocol for resuming training during the COVID-19 pandemic. It included personal history, antigen swabs, blood tests, spirometry, resting/stress-test ECG with oxygen saturation monitoring, echocardiogram, Holter and chest CT. We also compared the findings with prior data from the same subjects before infection and with data from SARS-CoV-2-negative players. RESULTS: None of the players had positive swab and/or anti-SARS-CoV-2 IgM class antibodies. Out of 30 players, 18 (60%) had IgG class antibodies. None had suffered severe SARS-CoV-2-related disease, 12 (66.7%) had complained of mild COVID-19-related symptoms and 6 (33.3%) were asymptomatic. None of the players we examined revealed significant cardiovascular abnormalities after clinical recovery. A mild reduction in spirometry parameters versus pre-COVID-19 values was observed in all athletes, but it was statistically significant (p<0.05) only in SARS-CoV-2-positive athletes. One SARS-CoV-2-positive player showed increased troponin I level, but extensive investigation did not show signs of myocardial damage. CONCLUSION: In this small cohort of athletes with previous asymptomatic/mild SARS-CoV-2 infection, a comprehensive screening protocol including blood tests, spirometry, resting ECG, stress-test ECG with oxygen saturation monitoring and echocardiogram did not identify relevant anomalies. While larger studies are needed, extensive cardiorespiratory and haematological screening in athletes with asymptomatic/mild SARS-CoV-2 infection appears unnecessary. BMJ Publishing Group 2021-01 2020-10-05 /pmc/articles/PMC7536638/ /pubmed/33020140 http://dx.doi.org/10.1136/bjsports-2020-102789 Text en © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Original Research
Gervasi, Salvatore Francesco
Pengue, Luca
Damato, Luca
Monti, Riccardo
Pradella, Silvia
Pirronti, Tommaso
Bartoloni, Alessandro
Epifani, Francesco
Saggese, Alessio
Cuccaro, Francesco
Bianco, Massimiliano
Zeppilli, Paolo
Palmieri, Vincenzo
Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
title Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
title_full Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
title_fullStr Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
title_full_unstemmed Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
title_short Is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild SARS-CoV-2 infection?
title_sort is extensive cardiopulmonary screening useful in athletes with previous asymptomatic or mild sars-cov-2 infection?
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7536638/
https://www.ncbi.nlm.nih.gov/pubmed/33020140
http://dx.doi.org/10.1136/bjsports-2020-102789
work_keys_str_mv AT gervasisalvatorefrancesco isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT pengueluca isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT damatoluca isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT montiriccardo isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT pradellasilvia isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT pirrontitommaso isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT bartolonialessandro isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT epifanifrancesco isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT saggesealessio isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT cuccarofrancesco isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT biancomassimiliano isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT zeppillipaolo isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection
AT palmierivincenzo isextensivecardiopulmonaryscreeningusefulinathleteswithpreviousasymptomaticormildsarscov2infection